3 Minute Depression Test & Screening. Get Instant Results – Based on the Depression Screening Test by Ivan Goldberg, M.D. – By Arnold Lieber, MD – Oct 2017
According to the NIMH Major depression is one of the most common mental disorders affecting more than 15 million adults in the United States (~6.7% of the population). Take this self-assessment test to see if you may be someone who could benefit from the treatment and support of a mental health professional.
The above quiz is based on the Patient Health Questionnaire (PHQ-9). If you think you may be suffering from Depression, PsyCom strongly recommends that you seek help from a doctor in order to receive a proper diagnosis and support.
Small acts of kindness at work benefit the giver, the receiver and the whole organisation – July 4, 2017 – By Alex Fradera
In the lab, psychologists have shown how generosity propagates and spreads.
If someone is kind to us, we tend to “pay it forward” and act more generously to someone else when given the chance. But it’s not clear if these findings are realistic.
For example, when we’re juggling priorities on a busy work day, might receiving an act of kindness actually be a nuisance, leaving us feeling indebted to return the favour when we’ve got more important things to do? Continue reading
Online Therapy Shows Promise But Raises Plenty Of Ethical Questions – May 2017 – by Jessica Goodheart
For pain patients who have trouble transporting themselves to the weekly appointments required for therapy, this could be a solution. However, I have doubts about how effective it could be for the supposed “catastrophizing” for which we are urged to seek therapy.
These were some of the “success stories” posted this month on the website of Sunnyvale-based BetterHelp, one of a handful of online therapy companies that substitutes the often hard-to-access office visit to a therapist’s office with a suite of online offerings.
Many who need mental health care can’t afford it, while many regions suffer a severe shortage of mental health professionals, and even in counties rich with therapists, many lack the time to make the visit. Continue reading
False economy? Half of “low intensity” CBT clients relapse within 12 months – By Christian Jarrett
Heralded as a revolution in mental health care – a cost-effective way to deliver evidence-based psychological help to large numbers – low-intensity Cognitive Behavioural Therapy (CBT) is recommended by NICE, the independent health advisory body in England and Wales, for mild to moderate depression and anxiety.
Prior studies into its effectiveness have been promising. However, little research has looked at whether the benefits last.
A new study in Behaviour Research and Therapy has done that, following a cohort of people with depression and anxiety over time. Continue reading
Study Answers Why Ketamine Helps Depression, Offers Target for Safer Therapy – June 21, 2017
UT Southwestern Medical Center scientists have identified a key protein that helps trigger ketamine’s rapid antidepressant effects in the brain, a crucial step to developing alternative treatments to the controversial drug being dispensed in a growing number of clinics across the country.
Ketamine is drawing intense interest in the psychiatric field after multiple studies have demonstrated it can quickly stabilize severely depressed patients.
But ketamine – sometimes illicitly used for its psychedelic properties – could also impede memory and other brain functions, spurring scientists to identify new drugs that would safely replicate its antidepressant response without the unwanted side effects. Continue reading
First Large-Scale Population Analysis Reinforces Ketamine’s Reputation as Antidepressant – Apr-2017
Better known as an anesthetic or as an illicit hallucinogenic drug, ketamine has also long been noted for alleviating depression.
But ketamine has not been tested in a large clinical trial, and all evidence of its antidepressant effects has come from anecdotes and small studies of fewer than 100 patients.
Now, in the largest study of its kind, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego mined the FDA Adverse Effect Reporting System (FAERS) database for depression symptoms in patients taking ketamine for pain. Continue reading
The One-Time Injection That Treats Depression – PsyBlog – undated, on after 2014
A single botox injection has been found to substantially improve depressive symptoms, research finds.
Botox is typically used to decrease the appearance of wrinkles in the face.
But, researchers have found that it can also help to treat the symptoms of depression.
For the study, 74 depressed people were given an injection to the facial muscles between the eyebrows — those related to frowning. Continue reading
Frontiers | Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up | Psychology for Clinical Settings – January 2017
This small study (39 patients) shows this type of therapy is effective for depression.
This randomized controlled trial examines the efficacy of metacognitive therapy (MCT) for depression.
Participants receiving MCT improved significantly more than the WL group. Continue reading
Hormone treatment of depression – NCBI – Dialogues Clin Neurosci. 2011 Mar – free fulll-text PMC article
Disorders of the thyroid axis have been closely linked to psychiatric disorders. While hyperthyroidism may present with a heterogenous range of psychiatric symptoms and syndromes, clinical hypothyroidism is invariably associated with depressive symptoms.
Although extensive research has shown that the vast majority of patients who present with major depression are euthyroid [normal thyroid], the close association between depression and hypothyroidism led to a large database of studies in which various hormones of the thyroid axis have been used to treat depression as monotherapy or, more commonly, as adjunct to standard antidepressants.
Each of the hormones of the thyroid axis will be reviewed. Continue reading
‘Let’s Talk’, WHO says, as depression rates rise 18 percent in a decade| Reuters – Mar 30, 2017 – By Kate Kelland
Depression is now the leading cause of ill health and disability worldwide, the World Health Organization (WHO) said on Thursday, with more than 300 million people suffering.
Rates of depression have risen by
more than 18 percent since 2005
WHO expressed concern that in many countries there is little or no support for people with mental health disorders, and said only around half of people with depression get treatment in wealthier nations.
On average just 3 percent of government health budgets is spent on mental health, varying from less than 1 percent in poor countries to 5 percent in rich ones, according to the WHO.